Journal of Leukocyte Biology Biosymposia, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published online as doi:10.1189/jlb.1002509 on May 22, 2003

Published online before print May 22, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1002509v1
73/6/722    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, M. J.
Right arrow Articles by Klein, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, M. J.
Right arrow Articles by Klein, N. J.
(Journal of Leukocyte Biology. 2003;73:722-730.)
© 2003 by Society for Leukocyte Biology

Severe meningococcal disease is characterized by early neutrophil but not platelet activation and increased formation and consumption of platelet–neutrophil complexes

M. J. Peters*,{dagger}, R. S. Heyderman{ddagger},§, S. Faust§, G. L. J. Dixon*, D. P. Inwald*,{dagger} and N. J. Klein*

* Infection and Microbiology Unit and
{dagger} Portex Unit Critical Care Group, Institute of Child Health, London, United Kingdom;
{ddagger} Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, United Kingdom; and
§ Department of Paediatrics, Imperial College School of Medicine (ICSM) at St. Mary’s, London, United Kingdom

Correspondence: Dr. M. J. Peters, Portex Unit Critical Care Group, Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK. E-mail: m.peters{at}ich.ucl.ac.uk


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Approximately 25% of polymorphonuclear leukocytes (PMNL) circulate in heterotypic complexes with one or more activated platelets. These platelet–neutrophil complexes (PNC) require platelet CD62P expression for their formation and represent activated subpopulations of both cell types. In this study, we have investigated the presence, time course, and mechanisms of PNC formation in 32 cases of severe pediatric meningococcal disease (MD) requiring intensive care. There were marked early increases in PMNL CD11b/CD18 expression and activation, and reduced CD62L expression compared with intensive care unit control cases. Minimal platelet expression of the active form of {alpha}IIbß3 (GpIIb/IIIa) was seen. PNC were reduced on presentation and fell to very low levels after 24 h. Immunostaining of skin biopsies demonstrated that PNC appear outside the circulation in MD. In vitro studies of anticoagulated whole blood inoculated with Neisseria meningitidis supported these clinical findings with marked increases in PMNL CD11b/CD18 expression and activation but no detectable changes in platelet-activated {alpha}IIbß3 or CD62P expression. In vitro PMNL activation with N. meningitidis (or other agonists) potentiated the formation of PNC in response to platelet activation with adenine diphosphate. Therefore, in severe MD, PMNL activation is likely to promote PNC formation, and we suggest that the reduced levels of PNC seen in established MD reflect rapid loss of PNC from the circulation rather than reduced formation.

Key Words: sepsis • adhesion • meningococcus • inflammation


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Haemostatic and inflammatory pathways intersect at a number of points, one of which is the binding of activated platelets to polymorphonuclear leukocytes (PMNL). The resulting platelet–neutrophil complexes (PNC) are formed by a multistep adhesion process [1 ] initiated by platelet CD62P-mediated adhesion to PMNL P-selectin glycoprotein ligand-1. This initial adhesion induces CD11b/CD18 (Mac-1) activation [2 ] via SRC kinases, which then firmly adhere to a second platelet ligand, probably fibrinogen bound to the activated form of the platelet integrin {alpha}IIb/ß3 (GpIIb/IIIa). Other molecules such as CD40 and CD40L found on the platelet also act to link the haemostatic and inflammatory pathways [3 ].

Circulating PNC can be observed in humans and may account for up to 25% of circulating PMNL [4 ]. These complexes appear to represent activated subpopulations of both cell types: Platelet activation with CD62P expression is required for PNC formation, and PMNL in PNC express higher levels of adhesion molecules, produce more superoxide, and phagocytose selected bacteria more readily than unbound neutrophils [5 , 6 ]. An increase in the formation of PNC, combining these platelet and PMNL properties, might be expected to contribute to the development of the haemostatic/inflammatory dysregulation, which underlies the systemic, inflammatory response.

Meningococcal disease (MD) is frequently associated with a severe systemic inflammatory response and progression to multiple organ failure characterized by shock, haemorrhagic skin lesions, and a marked coagulopathy. Platelets and PMNL are clearly implicated in the evolution of this process through the acceleration of thrombin production, cytokine and chemokine production, phagocytosis, and the release of reactive oxygen metabolites and proteases [7 , 8 ]. Thrombocytopenia and neutropenia are reliable signs of severe disease in patients with meningococcal septicaemia [9 ] and are thought to occur as a result of sequestration of both cell types in the microvasculature of the skin, lung, and other vital organs.

This disease is therefore an ideal scenario in which to investigate PNC formation and its relationship to platelet and PMNL activation and clinical severity. In this study, we have investigated the presence, time course, and mechanisms of PNC formation in 32 cases of severe pediatric MD requiring intensive care. We show that in the context of platelet and PMNL activation, PNC disappear from the circulation early in the course of meningococcemia and are detectable deep in the tissue lesions of these patients. In vitro studies of PNC formation with meningococci [10 ] lead us to suggest that the reduced numbers of circulating PNC seen in established MD may be explained by rapid loss from the circulation rather than reduced formation.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Materials
Mouse monoclonal antibodies (mAb) to CD11b conjugated to fluorescein isocyanate (FITC) and CD62L (L-selectin) conjugated to phycoerythrin (PE) were purchased from Serotec (Oxford, UK). Antibody 24 (Mab24), which binds to the activation site of CD11b/CD18, was a kind gift from Dr. Nancy Hogg (Imperial Cancer Reserach Fund, London) and was conjugated to FITC by standard techniques [11 ]. PE-conjugated mouse mAb to CD42b (glycoprotein Gp1b) and PE-conjugated mouse mAb to CD41 (IIb) were purchased from Dako (Cambridge, UK). FITC-conjugated mouse mAb to the activation site of {alpha}IIbß3 (CD41/CD61; GpIIb/IIIa) mAb Pac-1 was purchased from the Cell Centre (Department of Human Genetics, University of Pennsylvania, Philadelphia). FITC-conjugated mouse mAb to CD62P (P-selectin) and to CD66b were obtained from Pharminogen (Cowley, UK). Isotype and fluorochrome-matched, negative control immunoglobulin G (IgG)1 and IgM mAb were purchased from Serotec. Fluorescence-activated cell sorter (FACS) lysing solution was purchased from Becton Dickinson (Oxford, UK). Thrombin, glycyl-L-propyl-L-arginyl-L-proline (GPRP), adenosine diphosphate (ADP), f-Met-Leu-Phe (fMLP), and Escherichia coli lipopolysaccharide (LPS), protein content <1%, serotype O111:B4, were obtained from Sigma (Poole, UK).

Clinical studies, patients, and specimens
The local research ethics committees approved the protocols, and written consent was obtained. The diagnosis of MD was based on a characteristic petechial or purpuric rash with clinical features of sepsis and was confirmed by culture of meningococci from blood or by detection of meningococcal antigens or DNA (by polymerase chain reaction) in blood (PHLS Meningococcal Reference Unit, Manchester, UK). Circulating platelet, neutrophil activation, and PNC formation were studied in patients with a clinical diagnosis of meningococcal sepsis by one of the investigators (M.J.P. or G.L.J.D.) who accompanied the emergency pediatric retrieval team during stabilization and transport to the Pediatric Intensive Care Unit (PICU) at Great Ormond Street Hospital for Children (London). These studies were repeated on arrival and during the ICU stay. All samples were collected through indwelling arterial catheters to minimize collection artifact. The first 2 mL was discarded, and the required volume was collected into sodium citrate to a final concentration of 0.38%. The Pediatric Index of Mortality (PIM) [12 ] and the Glasgow Meningococcal Septicaemia Prognostic Score [13 ], which were recorded on first contact with the ICU team, determined severity of illness. The ICU mortality by day 28 was noted. Tissue leukocyte–platelet complexes were studied using 3 mm punch skin biopsies taken from the edge of the purpuric lesions of five cases within 24 h of the first dose of parenteral antibiotics. Control subjects were selected on the basis of cases ventilated on the PICU with single-system failure, without evidence of a systemic inflammatory response (raised white cell count, temperature, or tachycardia) [14 ].

Circulating PMNL activation
The levels of PMNL CD11b expression, CD11b/CD18 activation (as indicated by the binding of the mAb Mab24, which recognizes the active binding site of CD11b/CD18), and CD62L expression were measured by whole blood flow cytometry (Becton Dickinson FACScan and FASCalibur) as described previously [4 , 7 ]. On a forward- and orthogonal light-scatter, two-dimensional dot-plot, the PMNL population was distinguished from lymphocytes and monocytes and was CD66b-positive. Five thousand events were analyzed.

Circulating platelet activation
Changes in free platelet-activated {alpha}IIbß3 expression were measured by flow cytometry (Pac-1 antibody binding) using logarithmic light-scatter and fluorescence settings. Platelets were distinguished from other cells on the basis of their forward- and orthogonal light-scatter profile, and the accuracy of the gating was confirmed by staining with PE-labeled CD42b (>98%). Platelet responsiveness to ADP and thrombin (in the presence of GPRP to prevent fibrin cross-linking) was controlled for in each experiment.

PNC formation
As described previously [4 , 5 ], dual immunostaining was undertaken with a directly conjugated antibody against a platelet antigen (CD42b) and a directly conjugated antibody against a PMNL antigen (CD11b). Samples were then treated with FACSlyse and fixed with 0.2% formaldehyde. Events in the neutrophil population staining positive for neutrophil and platelet antigens were considered to represent PNC and were distinguishable from events staining for a neutrophil marker alone. PNC were expressed as the percentage of the total neutrophil population with associated platelets.

Immunohistochemistry
Formalin-fixed, paraffin-embedded sections were immunostained for platelets (CD41), PMNL (neutrophil elastase), and monocyte (CD68) markers using a novel horseradish peroxidase-labeled polymer system (Envision++, Dako) [15 ]. Microwave heat induction, antigen retrieval in citrate buffer, pH 6.0 (HDS05, SD Supplies, Aylesbury, UK), was required for optimal staining with the anti-CD41.

Whole blood model of meningococcal bacteraemia
This was performed as described previously using the following Neisseria meningitidis strains: NCTC 10025 (A: 4.NT); NCTC 10026 (B: NT.NT); NCTC 8554 (C: NT.P1.5); and strain 107770 [nongroupable (unencapsulated): 15.NT; 10]. In addition, N. meningitidis wild-type (WT) H44/76 (B: 15:P1.7,16) and a LPS-deficient lpxA– mutant [16 ] were used to further characterize PNC formation and neutrophil activation. Stationary-phase meningococci grown overnight on GC agar (Difco, Detroit, MI) supplemented with 1% Vitox (Oxoid, Basingstoke, Hampshire, UK) were used [10 ]. To minimize variation between experiments, a single, healthy donor was used. Subsequent experiments to confirm our findings were conducted using blood obtained from further six healthy, adult volunteers. Blood was collected without stasis; the first 2 mL drawn was discarded, and the remainder was anticoagulated with 3.8% sodium citrate. Aliquots (5 mL) of whole blood were then inoculated with meningococci (at final concentration, 106–108 cfu/mL) and were then incubated on a rocking platform at 9 rpm at 37°C [17 ]. At specific time intervals, aliquots of blood were removed for analysis of platelet activation and PNC formation as described above. Red blood cell and platelet counts did not fall over the 60-min period of observation, and haemolysis was not observed in separated samples. Beyond 60 min, significant PMNL and platelet activation occur in unstimulated, control samples [4 , 10 ]; therefore, this model was not examined after longer incubations.

Statistics
Experiments were performed on at least four occasions. Data are presented as median and interquartile ranges (IQR) or mean and standard errors when normally distributed. The differences between the groups were analyzed by a Wilcoxon-sum ranked tests or paired t-tests as appropriate.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
Patients
Twenty-seven cases of severe meningococcal septicaemia referred to the ICU were studied for circulating platelet and PMNL adhesion molecule expression and PNC formation. This population included six deaths, five of which occurred in the first 12 h of the disease from profound cardio-respiratory failure. The characteristics of these patients including severity-of-illness scores are presented in Table 1 . Initial samples were collected at a median of 9 h (IQR, 5–16; range, 1–24) after the first dose of parenteral antibiotics.


View this table:
[in this window]
[in a new window]
  		Table 1. Characteristics of 27 Cases of Acute MD Studied on the PICU at Great Ormond Street Hospital

 
PMNL adhesion molecule expression
Increased expression of PMNL CD11b/CD18 was seen in all subjects with meningococcal sepsis assessed within 24 h of presentation when compared with 20 "PICU controls", patients with single-system failure and no clinical evidence of systemic inflammation [14 ] (respiratory syncitial virus pneumonia, n=5; asthma, n=5; acute central nervous system disease, n=4; postoperative upper airway or abdominal surgery, n=6; P=0.008). Levels of PMNL CD11b expression in eventual nonsurvivors (Table 1) of MD were significantly higher (P=0.02) than survivors. Circulating PMNL CD11b expression decreased in later samples (>24 h) in all MD cases surviving more than 24 h. This pattern was mirrored by CD11b/CD18 activation as assessed by Mab24 binding. CD62L expression was significantly decreased (P=0.01) in patients with MD compared with PICU controls (Fig. 1 ), but the difference between survivors and nonsurvivors did not reach statistical significance. On review, at day 28, PMNL adhesion molecule expression was indistinguishable from controls in six cases studied (results not shown).



View larger version (15K):
[in this window]
[in a new window]
  		Figure 1. Circulating PMNL activation in 27 cases of acute MD. (A) CD11b expression, (B) activation of CD11b/CD18 (Mab24 binding), and (C) CD62L expression are compared with control values (mean and 95% confidence intervals) observed in 20 control PICU patients. Solid circles represent nonsurvivors and open circles, survivors.

 
Platelet-integrin activation
Activation of platelet {alpha}IIbß3 was assessed in 18 subjects (including five nonsurvivors) with MD within 24 h of presentation (Fig. 2 ). Compared with controls, individuals had a greater than 50% increase in activated {alpha}IIbß3. However, overall, the median value was no different from PICU controls (median, range), there was a trend toward lower levels of {alpha}IIbß3 activation in fatal cases, and there is no clear pattern observed with the time course of the disease.



View larger version (17K):
[in this window]
[in a new window]
  		Figure 2. Circulating platelet {alpha}IIbß3 activation in acute MD. Circulating platelets (n=18) are not significantly more activated than control PICU cases (n=8, median and IQR shown). There is a trend toward lower levels of {alpha}IIbß3 activation in fatal cases, and no clear pattern is observed with the time course of the disease. Solid circles represent nonsurvivors and open circles, survivors.

 
PNC
The proportion of circulating PMNL associated with one or more platelets (PNC) was assessed in 23 cases (including six nonsurvivors) within 24 h of presentation. Circulating PNC were reduced on presentation as compared with PICU controls. Levels fell further when assessed between 24 and 48 h after presentation (Fig. 3 ). The level of PNC on presentation was inversely correlated with disease severity, as assessed by GMSPS (Pearson correlation, r=-0.51; P=0.01; data not shown). This effect was independent of platelet count (partial correlation coefficient GMSPS vs. PNC corrected for platelet count, r=–0.58; P=0.006). There were no significant differences in levels of PNC seen between eventual survivors and nonsurvivors on univariate analysis (Table 1) . On review at day 28, PNC were observed at levels equivalent to controls in six cases studied (results not shown).



View larger version (18K):
[in this window]
[in a new window]
  		Figure 3. PNC in 23 cases of acute MD. Control values for PNC (mean and 95% confidence intervals are shown) were observed in PICU-control patients (n= 20). Solid circles represent nonsurvivors and open circles, survivors. There was a reduced level of PNC on presentation, which reduced further between 24 and 48 h.

 
Effect of platelet transfusion
Platelet count might be anticipated to have a major influence on the observed level of PNC. However, admission platelet counts did not correlate with the coincident level of PNC (r=0.17; P=0.47). In seven cases in which samples could be obtained before and in the 12 h after therapeutic platelet transfusion, no significant changes in PNC (Wilcoxon-signed ranks test, P=1.0) or {alpha}IIbß3 expression staining (P=0.5; Fig. 4 ) were observed. This was despite a significant increase in circulating platelet count (P=0.018).



View larger version (11K):
[in this window]
[in a new window]
  		Figure 4. The effect of platelet transfusion on platelet count, % PNC, and {alpha}IIbß3 (Pac-2 MFI) activation. Paired observations in seven patients in before and after platelet transfusion are shown. There is a significant increase in platelet count but no change in % PNC or {alpha}IIbß3 activation. These data support the interpretation of the fall in PNC shown above (Fig. 3) as a true change rather than an artifact of altered platelet counts.

 
Immunohistochemistry on skin biopsies of acute MD
As reported previously, the general tissue structure of all biopsies was well preserved and showed evidence of thrombosis and frequently, a perivascular acute inflammatory cell infiltrate [18 ]. This cellular infiltrate consisted of PMNL and monocytes [19 ]. Leukocyte–platelet complexes (CD41-positive) were observed in all five biopsies (Fig. 5 ). Using a double-staining technique, CD68-positive and neutrophil elastase-positive leukocyte–platelet complexes were observed. These complexes were rarely seen inside blood vessels and were often observed deep in within the interstitium.



View larger version (77K):
[in this window]
[in a new window]
  		Figure 5. Platelet–neutrophil complexes in meningococcal disease. Immunoperoxidase staining of skin biopsies from five children with MD (examples shown in A and B) showing evidence of a perivascular acute inflammatory cell infiltrate of PMNL and monocytes. Leukocyte–platelet complexes (CD41-positive) were observed (arrowed). These complexes were rarely seen inside blood vessels and were often observed deep in the periphery.

 
Mechanisms of PNC formation in a whole blood model of MD
Following inoculation of anticoagulated whole blood with N. meningitidis H44/76, marked PMNL activation, as evidenced by a dose-dependent increase in CD11b expression and CD11b/CD18 activation (Mab24 binding), was observed (Fig. 6 ). These changes were not entirely endotoxin-dependent, as CD11b expression and Mab24 binding were seen when these experiments were repeated using the LPS-deficient isogenic mutant (lpxA–) at a high concentration (108 cfu/mL).



View larger version (14K):
[in this window]
[in a new window]
  		Figure 6. PMNL CD11b expression and CD11b/CD18 activation in the whole blood model of MD. (A) CD11b expression is significantly increased following 30 min incubation with WT N. meningitides in a dose-dependent manner across a range of concentrations from 106 to 108 cfu/mL. Means and standard errors of eight experiments are shown. *, P < 0.05, and **, P < 0.01, in paired t-test versus control samples at 30 min. Incubation with the LPS-deficient mutant (LPXa) N. meningitides induces an increase in CD11b at 108 cfu/mL only. (B) CD11b/CD18 activation indicated by Mab24 binding follows an identical pattern.

 
Using the same model, we found no evidence of platelet activation in response to N. meningitidis, as assessed by activated {alpha}IIbß3 expression or up-regulation of CD62P expression (Fig. 7 ). Platelet degranulation, as measured by release of immunoreactive ß-thromboglobulin, also did not increase following whole blood inoculation with live meningococci (data not shown). Marked changes in platelet activation were seen following stimulation with the agonists ADP or thrombin, indicating that platelet function was not affected by the experimental conditions. Neither purified LPS nor the bioactive peptide fMLP caused detectable increases in CD62P expression or {alpha}IIbß3 activation (data not shown).



View larger version (26K):
[in this window]
[in a new window]
  		Figure 7. Lack of detectable platelet activation in the whole blood model of MD. The mean and standard error of four experiments are shown. (A) {alpha}IIbß3 (GpIIb/IIIa) and (B) CD62P expression remains unchanged despite incubation with a range of serogroups of N. meningitidis.

 
When PNC were measured in this system, no significant changes were seen following incubation with 106–108 cfu/mL WT N. meningitidis H44/76, despite increased CD11b expression and Mab24 binding. However, costimulation with the platelet agonist ADP (10 mM) and N. meningitidis caused significant potentiation of PNC formation above that seen with ADP alone. This was seen with all concentrations of bacteria and with purified LPS (Fig. 8 ). As some authors have suggested a direct effect of LPS on platelet aggregability, this response was investigated with the lpxA– strain and the bioactive peptide fMLP. As with the WT N. meningitides, no change in PNC was seen at rest, but the response to ADP was potentiated (Fig. 8) . It is interesting that only the combination of ADP and the highest dose of lpxA– (108 cfu/mL) had a significant effect on PNC formation. As with N. meningitidis, neither purified LPS nor fMLP caused detectable increases in CD62P expression or {alpha}IIbß3 activation (data not shown).



View larger version (37K):
[in this window]
[in a new window]
  		Figure 8. PNC formation in vitro; the whole blood model of MD: the relative contributions of platelet and PMNL activation. (A) WT N. meningitidis at 106–108 organisms/mL caused no increase in PNC. As expected, the platelet agonist ADP induced increased PNC formation under all conditions, but this effect was significantly potentiated by coincubation with N. meningitidis or purified LPS. (B) The potentiation of PNC formation in response to ADP is also seen in response to non-LPS-mediated neutrophil activation with the peptide fMLP or the LPXa strain of LPS-deficient meningococci (at 108 organisms/mL only). The mean and standard errors of at least four experiments are shown. The results of paired t-test against paired control levels of PNC in samples stimulated with ADP alone are shown.

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
It has been recognized for many years that platelets and PMNL are implicated in the evolution of severe MD. However, information on how these cells interact in vivo is limited. In this study, we have shown for the first time that complexes of PMNL and platelets are reduced in the blood of patients with severe MD. This is in the context of detectable, circulating PMNL activation and minimal platelet activation, as assessed by the expression and activation of adhesion molecules. These results raise many questions concerning the activation and recruitment of PMNL and platelets, individually and within complexes, in MD.

Platelet activation and consumption are key features of severe MD to the extent that thrombocytopenia is considered a clinically useful prognostic indicator, and thrombosed vessels are prominent on histological examination [18 , 20 ]. In spite of this clear evidence of platelet involvement in MD, we were unable to demonstrate any significant activation of circulating platelets in patients with this condition. The lack of platelet activation in a relevant clinical setting is a frequent finding and is thought to be largely a result of consumption of the most activated platelets, leaving only the quiescent cells available for sampling [4 , 21 ]. This view is supported by recent studies in baboons in which labeled thrombin-activated platelets could only be detected briefly in the circulation following a platelet transfusion [20 ]. Taken together, the results from this and other studies indicate that detection of platelet activation in vivo is dependent on the balance between activation and recruitment. This balance will vary with the underlying disease process, age of patients, and timing of sampling [22 , 23 ].

Although it is apparent that platelet activation is occurring in MD patients, even if this is difficult to demonstrate in vivo, the stimuli required for platelet activation in this disease are unclear. One possibility is that N. meningitidis itself could directly activate platelets. Despite in vitro studies implicating endotoxin as stimulant of platelets [24 25 26 27 28 ], our own studies of direct stimulation of whole blood with high concentrations of meningococci failed to induce changes in platelet adhesion molecule expression or activation. This was independent of meningococcal serogroup, bacterial concentration, and blood donor. Our data would support a view that platelet activation in MD occurs through other mechanisms.

The mechanisms of the coagulopathy of severe systemic inflammation have been extensively investigated, and known key elements include activation of the tissue factor (TF) pathway by endothelial and monocyte TF expression; consumption or inhibition of endogenous anticoagulant (e.g., antithrombin III, protein C); and fibrinolytic capacity by increased plasminogen activator inhibitor-1 and possibly reduced activation of protein C [29 , 30 ]. All these processes lead to increased and prolonged thrombin production and in the absence of a direct bacterial effect, are more likely to be the initial stimulants for platelet activation in MD. This is consistent with the clinical observation that the most extreme thrombocytopenia occurs after the most profound neutropenia in severe MD [9 ].

The role of PMNL in sepsis is complex [31 ]. Although PMNL phagocytosis of microorganisms is fundamentally important in the initial response to invasive bacterial infection, there is also evidence that these cells may be responsible for much of the tissue injury evident in multiorgan failure following sepsis [32 33 34 ]. Neutrophils are constitutively short-lived, undergoing apoptosis in a matter of hours. Factors that delay this process are associated with more severe organ failure [32 ].

Clinical studies of patients with severe sepsis such as this are limited by the wide variability in the presentation, age, ethnic origin, and timing of sample collection. Despite this, we observed a consistent pattern of early, marked PMNL activation with high levels of CD11b expression and activation and reduced CD62L expression. Activated PMNL are likely to attach to endothelial cells and to transmigrate from the circulation, but clearly the rate at which this adhesion takes place will affect the detectable levels of activation in the residual circulating population. In spite of the variety of potential fates for an activated PMNL in a septic blood vessel, we found increased PMNL CD11b expression and Mab24 binding early in the course of clinical MD. Indeed, significantly higher levels of CD11b expression and activation were seen in eventual nonsurvivors. This may reflect inhibition of normal PMNL chemotactic function in the severely ill [35 , 36 ]. Some suggestion that the more activated PMNL are most rapidly recruited is provided by the observed, inverse correlation between the log of the neutrophil count and CD11b expression (r=–0.7; P=0.01) or activation (Mab24 binding, r=–0.7; P<0.001). As was the case with platelets, a dynamic relationship between activation and recruitment exists for PMNL and will influence the properties of any remaining, circulating neutrophils. ß2 Integrin expression activation declined rapidly in MD patients surviving more than 24 h. This may be explained by a reduction in the levels of agonists such as tumor necrosis factor {alpha} or LPS. However, the role of PMNL in the pathogenesis of sepsis is not limited to the first 24 h [37 ], and an alternative explanation of this fall in neutrophil activation is a shift from early disease when there may be a large pool of PMNL circulating in an activated state but with a relative deficiency of endothelial-adhesive counter-receptors toward a "higher flow" state with greater marrow output and rapid recruitment of the more activated PMNL to the now very widespread, activated endothelial cells. In our whole blood model, there was an increase in CD11b and Mab24 binding within minutes of stimulation with bacterial agonists, as expected from previous studies [17 , 23 , 38 ]. In contrast to the in vitro studies, the activated PMNL adhesion molecule profile persisted in this model [17 , 23 , 38 ]. Although care must be taken when comparing findings in the brief (60-min) in vitro model with the more complex and slowly evolving clinical scenario, the whole blood model contains no endothelium, and therefore, the potential for recruitment of the more activated neutrophils must be reduced.

In this context, our observation that in patients with MD, PNC were almost undetectable by 24 h is pertinent. Our previous studies have shown that PNC represent a subpopulation of activated PMNL and platelets [5 ]. As such, they are likely to be particularly adhesive, as they are able to bind through PMNL and platelet adhesion systems. In our whole blood experiments, we were able to show that PNC formation occurs at a significantly enhanced rate in the presence of N. meningitidis and platelet activation. The role of PMNL ß2 integrin and platelet {alpha}IIbß3 in this enhancement is the subject of ongoing work.

In contrast, PNC formation in vivo appears to be rapidly followed by PNC loss from the circulation. Similar observations have been made in baboons in which PNC numbers were only increased for a median of 5 min after labeled, activated platelet transfusion [5 , 20 ]. Similarly, changes in PNC numbers in patients are not explained by a coincident fall in platelet count because of the lack of effect of platelet transfusion on PNC numbers. Therefore, it would appear that PNC are formed in the presence of stimuli to PMNL and platelets but are then recruited, probably to sites of vascular injury. We have previously demonstrated that PNC are reduced in the presence of transiently injured endothelium (as shown by loss of endothelial vasodilator function) in a human model of ischaemia-reperfusion injury [21 ]. The acute, inflammatory states of cardiopulmonary bypass [39 ] and multiple organ failure [22 , 40 ] have also been associated with reduced PNC. The presence of PNC in skin biopsy specimens from patients with MD provides further support for the formation and recruitment of PNC in disease states.

The relationship among PMNL, platelets, bacteria, and cytokines is considered to be central to our understanding of sepsis. It is interesting that recent data indicate that platelet-derived cytokines delay PMNL apoptosis [41 ], which is a key feature in the generation of sepsis-induced organ injury [32 ]. This study provides further support for the interaction of activated platelets to PMNL in PNC having a pathophysiological role in acute, severe inflammation. Future studies are needed to confirm PNC as a central point of interaction between the inflammatory and haemostatic pathways.


   ACKNOWLEDGEMENTS
 
This work was supported by Clinical Training Fellowships from the Medical Research Council (UK; Drs. Inwald and Faust), The Royal College of Physicians (Dr. Dixon), and a project grant from the Meningitis Research Foundation (Dr. Heyderman). We are grateful to Dr. C. Ison and Professor M. Levin for their expert help and advice. We gratefully acknowledge the Pediatric Intensive Care clinical teams at Great Ormond St. Hospital and St. Mary’s Hospital.

Received October 26, 2002; revised February 12, 2003; accepted February 19, 2003.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Evangelista, V., Manarini, S., Rotondo, S., Martelli, N., Polischuk, R., McGregor, J. L., de Gaetano, G., Cerletti, C. (1996) Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18 Blood 88,4183-4194[Abstract/Free Full Text]
  2. Evangelista, V., Manarini, S., Sideri, R., Rotondo, S., Martelli, N., Piccoli, A., Totani, L., Piccardoni, P., Vestweber, D., de Gaetano, G., Cerletti, C. (1999) Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signalling molecule Blood 93,876-885[Abstract/Free Full Text]
  3. Henn, H., Slupsky, J. R., Grafe, M., Anagnostopoulos, I., Forster, R., Muller-Berghaus, G., Kroczek, R. A. (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Nature 391,591-594[CrossRef][Medline]
  4. Peters, M., Heyderman, R. S., Hatch, D. J., Klein, N. J. (1997) Investigation of platelet-neutrophil interactions in whole blood by flow cytometry J. Immunol. Methods 209,125-135[CrossRef][Medline]
  5. Peters, M. J., Dixon, G. D., Kotowicz, K. T., Hatch, D. J., Heyderman, R. S., Klein, N. J. (1999) Circulating platelet-neutrophil complexes represent a subpopulation of neutrophils primed for adhesion, phagocytosis and intracellular killing Br. J. Haematol. 106,391-399[CrossRef][Medline]
  6. Nagata, K., Tsuji, T., Todoroki, N., Katagiri, Y., Tanoue, K., Yamazaki, H., Hanai, N., Irimura, T. (1993) Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62) J. Immunol. 151,3267-3273[Abstract]
  7. Klein, N. J., Levin, M., Strobel, S., Finn, A. (1993) Degradation of glycosaminoglycans and fibronectin on endotoxin-stimulated endothelium by adherent neutrophils: relationship to CD11b/CD18 and L-selectin expression J. Infect. Dis. 167,890-898[Medline]
  8. Zimmerman, G. A., Prescott, S. M., McIntyre, T. M. (1995) Endothelial cell interactions with granulocytes: tethering and signalling molecules Immunol. Today 13,93-100
  9. Peters, M. J., Ross-Russell, R. I., White, D., Kerr, S. J., Eaton, F. E. M., Keengwe, I. N., Tasker, R. C., Wade, A. M., Klein, N. J. (2001) Early severe neutropenia and thrombocytopenia identifies the highest risk cases of acute meningococcal disease Pediatr. Crit. Care Med. 2,225-231[Medline]
  10. Ison, C. A., Heyderman, R. S., Klein, N. J., Peakman, M., Levin, M. (1995) Whole blood model of meningococcal bacteraemia–a method for exploring host-bacterial interactions Microb. Pathog. 18,97-107[CrossRef][Medline]
  11. Johnson, G. D., Holborow, E. J. (1973) Immunofluorescence Weir, D. M. eds. Handbook of Experimental Immunology ,1-20 Blackwell Scientific Oxford, UK.
  12. Shann, F., Pearson, G., Slater, A., Wilkinson, K. (1997) Paediatric index of mortality (PIM): a mortality prediction model for children in intensive care Intensive Care Med. 23,201-207[CrossRef][Medline]
  13. Sinclair, J. F., Skeoch, C. H., Hallworth, D. (1987) Prognosis of meningococcal septicaemia Lancet 2,38[Medline]
  14. Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M., Sibbald, W. J. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101,1644-1655[Abstract/Free Full Text]
  15. Sabattini, E., Bisgaard, K., Ascani, S., Poggi, S., Piccioli, M., Ceccarelli, C., Pieri, F., Fraternali-Orcioni, G., Pileri, S. A. (1998) The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques J. Clin. Pathol. 51,506-511[Abstract]
  16. Uronen, H., Williams, A. J., Dixon, G., Andersen, S. R., Van Der Ley, P., Van Deuren, M., Callard, R. E., Klein, N. (2000) Gram-negative bacteria induce proinflammatory cytokine production by monocytes in the absence of lipopolysaccharide (LPS) Clin. Exp. Immunol. 122,312-315[CrossRef][Medline]
  17. Klein, N. J., Ison, C. A., Peakman, M., Levin, M., Hammerschmidt, S., Frosch, M., Heyderman, R. S. (1996) The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis J. Infect. Dis. 173,172-179[Medline]
  18. Faust, S. N., Levin, M., Harrison, O. B., Goldin, R. D., Lockhart, M. S., Kondaveeti, S., Laszik, Z., Esmon, C. T., Heyderman, R. S. (2001) Dysfunction of endothelial protein C activation in severe meningococcal sepsis N. Engl. J. Med. 345,408-416[Abstract/Free Full Text]
  19. Harrison, O. B., Robertson, B. D., Faust, S. N., Jepson, M. A., Goldin, R. D., Levin, M., Heyderman, R. S. (2002) Analysis of pathogen-host cell interactions in purpura fulminans: expression of capsule, type IV pili, and PorA by Neisseria meningitidis in vivo Infect. Immun. 70,5193-5201[Abstract/Free Full Text]
  20. Michelson, A. D., Barnard, M. R., Krueger, L. A., Valeri, C. R., Furman, M. I. (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction Circulation 104,1533-1537[Abstract/Free Full Text]
  21. Kharbanda, R. K., Peters, M., Walton, B., Kattenhorn, M., Mullen, M., Klein, N., Vallance, P., Deanfield, J., MacAllister, R. (2001) Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo Circulation 103,1624-1630[Abstract/Free Full Text]
  22. Gawaz, M., Dickfeld, T., Bogner, C., Fateh Moghadam, S., Neumann, F. J. (1997) Platelet function in septic multiple organ dysfunction syndrome Intensive Care Med. 23,379-385[CrossRef][Medline]
  23. Russwurm, S., Vickers, J., Meier-Hellmann, A., Spangenberg, P., Bredle, D., Reinhart, K., Losche, W. (2002) Platelet and leukocyte activation correlate with the severity of septic organ dysfunction Shock 17,263-268[CrossRef][Medline]
  24. Vincent, J. L., Yagushi, A., Pradier, O. (2002) Platelet function in sepsis Crit. Care Med. 30,S313-S317[CrossRef][Medline]
  25. Saluk-Juszczak, J., Wachowicz, B., Zielinski, T., Kaca, W. (2001) Adhesion of thrombin-stimulated and unstimulated blood platelets to collagen in the presence of Proteus mirabilis lipopolysaccharides Platelets 12,470-475[CrossRef][Medline]
  26. Mirlashari, M. R., Hagberg, I. A., Lyberg, T. (2002) Platelet-platelet and platelet-leukocyte interactions induced by outer membrane vesicles from N. meningitidis Platelets 13,91-99[Medline]
  27. Saba, H. I., Saba, S. R., Morelli, G., Hartmann, R. C. (1984) Endotoxin-mediated inhibition of human platelet aggregation Thromb. Res. 34,19-33[CrossRef][Medline]
  28. Csako, G., Suba, E. A., Elin, R. J. (1988) Endotoxin-induced platelet activation in human whole blood in vitro Thromb. Haemost. 59,378-382[Medline]
  29. Opal, S. M., Cohen, J. (1999) Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit. Care Med. 27,1608-1616[CrossRef][Medline]
  30. Esmon, C. T. (2001) Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation Crit. Care Med. 29,S48-S51[CrossRef][Medline]
  31. Marshall, J. C. (2000) Complexity, chaos, and incomprehensibility: parsing the biology of critical illness Crit. Care Med. 28,2646-2648[CrossRef][Medline]
  32. Marshall, J. C., Hui Jia, S., Taneja, R. (2002) Dysregulated Neutrophil Apoptosis in the Pathogenesis of Organ Injury in Critical Illness Evans, T. A. Fink, M. P. eds. Mechanisms of Organ Dysfunction in Critical Illness ,110-123 Springer Berlin.
  33. Weiss, S. J. (1989) Tissue destruction by neutrophils N. Engl. J. Med. 320,365-376[Medline]
  34. Fujishima, S., Aikawa, N. (1995) Neutrophil-mediated tissue injury and its modulation Intensive Care Med. 21,277-285[CrossRef][Medline]
  35. Tavares-Murta, B. M., Zaparoli, M., Ferreira, R. B., Silva-Vergara, M. L., Oliveira, C. H., Murta, E. F., Ferreira, S. H., Cunha, F. Q. (2002) Failure of neutrophil chemotactic function in septic patients Crit. Care Med. 30,1056-1061[CrossRef][Medline]
  36. Tanowitz, H. B., Weiss, L. M., Chan, J. (2002) Neutrophil migration and sepsis Crit. Care Med. 30,1169-1170[CrossRef][Medline]
  37. Watson, R. W., Rotstein, O. D., Nathens, A. B., Parodo, J., Marshall, J. C. (1997) Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement J. Immunol. 158,945-953[Abstract]
  38. Heyderman, R. S., Ison, C. A., Peakman, M., Levin, M., Klein, N. J. (1999) Neutrophil response to Neisseria meningitidis: inhibition of adhesion molecule expression and phagocytosis by recombinant bactericidal/permeability-increasing protein (rBPI21) J. Infect. Dis. 179,1288-1292[CrossRef][Medline]
  39. Rinder, C. S., Gaal, D., Student, L. A., Smith, B. R. (1994) Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass J. Thorac. Cardiovasc. Surg. 107,280-288[Abstract/Free Full Text]
  40. Peters, M., Dixon, G. D., Tasker, R. C., Klein, N. J. (1998) Platelet-neutrophil complexes in multi-organ dysfunction syndrome Intensive Care Med. 24,S176(abstract)
  41. Brunetti, M., Martelli, N., Manarini, S., Mascetra, N., Musiani, P., Cerletti, C., Aiello, F. B., Evangelista, V. (2000) Polymorphonuclear leukocyte apoptosis is inhibited by platelet-released mediators, role of TGFbeta-1 Thromb. Haemost. 84,478-483[Medline]



This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
K. Yoshida, R. Kondo, Q. Wang, and C. M. Doerschuk
Neutrophil Cytoskeletal Rearrangements during Capillary Sequestration in Bacterial Pneumonia in Rats
Am. J. Respir. Crit. Care Med., September 15, 2006; 174(6): 689 - 698.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Trujillo and R. R. Kew
Platelet-Derived Thrombospondin-1 Is Necessary for the Vitamin D-Binding Protein (Gc-Globulin) to Function as a Chemotactic Cofactor for C5a
J. Immunol., September 15, 2004; 173(6): 4130 - 4136.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1002509v1
73/6/722    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, M. J.
Right arrow Articles by Klein, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, M. J.
Right arrow Articles by Klein, N. J.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS